NL-OMON47998
Recruiting
Not Applicable
ongitudinal European Autism Project (LEAP). Follow-up-2 (wave-3) - LEAP-3
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- autism
- Sponsor
- Radboud Universitair Medisch Centrum
- Enrollment
- 288
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Having participated in LEAP\-1 and/or LEAP\-2; the criteria observed at wave\-1
- •1\. Male or female aged 6\-30 years with an established clinician diagnosis of
- •Autism Spectrum Disorder according to DSM\-5 criteria;
- •2\. Male or female with an IQ of 50 or above;
- •3\. Able to participate and willing to give written informed consent;
- •(a) Where participants are their own legal guardian (i.e. aged 18 years and
- •older without intellectual disabilities and demonstrated capacity to consent),
- •written informed consent from the volunteer;
- •(b) Where participants are minors and/or do not have capacity to consent,
- •written informed consent from the parent or legal guardian; verbal assent from
Exclusion Criteria
- •All groups:
- •1\. Presence of significant hearing or visual impairments not correctable by
- •glasses or hearing aids;
- •2\. A history of alcohol and / or substance abuse or dependence in the past
- •3\. Presence of any MRI counter\-indications (e.g., metal implants, braces,
- •claustrophobia) or failure to give informed written consent to MRI scanning (or
- •to provide GP details at centres where this is a pre\-condition for scanning);
- •4\. Presence or history of any Neurological Disorder/ significant trauma.
- •Presence of psychosis or bipolar disorder.
- •Presence of any DSM\-5 axis I and II psychiatric disorders.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
EU-AIMS Longitudinal European Autism Project (EU-AIMS LEAP): an exploratory studyAutism10012562NL-OMON40536niversitair Medisch Centrum Sint Radboud300
Completed
Not Applicable
A program for ALS Care in EuropeAmyotropic Lateral Sclerosis (ALS) muscle disease10029317NL-OMON46176divisie hersenen120
Recruiting
Not Applicable
Australian Epilepsy ProjectACTRN12623000008628Florey Institute of Neuroscience and Mental Health4,000
Active, not recruiting
Not Applicable
Multinational européan trial for children with the opsoclonus myoclonus syndrome/dancing eye syndrome.MedDRA version: 16.0Level: PTClassification code 10053854Term: Opsoclonus myoclonusSystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2011-000990-29-SEINSTITUT CURIE100
Active, not recruiting
Phase 1
Multinational européan trial for children with the opsoclonus myoclonus syndrome/dancing eye syndrome.Opsoclonus myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in childrenwith and without neuroblastoma (NBpos and NBneg)MedDRA version: 15.0Level: PTClassification code 10053854Term: Opsoclonus myoclonusSystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2011-000990-29-FRINSTITUT CURIE100